Press releases
- Prothena Reports First Quarter 2024 Financial Results and Business Highlights
- Prothena to Report First Quarter 2024 Financial Results on May 8
- Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
- Prothena to Participate in Upcoming Healthcare Conferences
Key statistics
As of last trade Prothena Corporation PLC (0Y3M:LSE) traded at 20.09, 1.36% above its 52-week low of 19.82, set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 20.09 |
Average volume | 97.44 |
---|---|
Shares outstanding | 53.77m |
Free float | 47.09m |
P/E (TTM) | -- |
Market cap | 1.08bn USD |
EPS (TTM) | -3.25 USD |
Data delayed at least 20 minutes, as of May 23 2024 19:11 BST.
More ▼